Article

Patrick Geraghty Discusses the Relationship Between Health Plans and its Membership

Mr. Geraghty points out a variety of ways to engage a health plan's members.

Patrick Geraghty, Chairman & CEO, Blue Cross Blue Shield of Florida, states that community outreach helps a great deal in building trust with Florida Blue's membership. Engaging the consumers personally with community service and online tools will also strengthen the relationship a health plan has with its members.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Surbhi Sidana, MD, MBBS, Stanford University
Gordon Crofoot, MD, PA
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Related Content
Venetoclax showed “remarkable efficacy” in older patients, with an response rate of 91% in the octogenarian group—similar to what has been reported in younger cohorts. | Image credit: sovova - stock.adobe.com
June 20th 2025

Venetoclax Effective in Older Patients With CLL

Jared Kaltwasser
Venetoclax demonstrated impressive efficacy in octogenarians with CLL, although treatment management posed some challenges.
Logo for Managed Care Cast
June 19th 2025

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Maggie L. Shaw Colin Banas, MD, MHA
Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Hamlet Gasoyan, PhD
June 19th 2025

Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD

Hayden E. Klein Hamlet Gasoyan, PhD
Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
managed care cast logo
June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS
Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Westin Forrestal Princeton | Image: Westin
June 19th 2025

Value-Based Care Calls for Putting Novel Therapies Closer to Patients

Mary Caffrey
Coverage from IVBM Princeton, held May 8, 2025.
Patients with SCLC in the tarlatamab group had significantly longer overall survival, with a median of 13.6 months vs 8.3 months in the chemotherapy group. | Image credit: mi_viri - stock.adobe.com
June 19th 2025

Tarlatamab Improves SCLC Outcomes After Platinum Chemotherapy

Jared Kaltwasser
Median overall survival was 5 months longer in patients with small cell lung cancer (SCLC) who received tarlatamab instead of chemotherapy after progression following platinum-based chemotherapy.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo